Skip to main content

UPC Advisory

Uniform Practice Code Advisories are notices that pertain to unusual circumstances such as extremely large dividends, when-issued settlement dates, ex-interest dates for bonds, worthless securities, cancelled IPOs, etc. Their intent is to announce rulings, interpretations, exemptions and advisories on these subjects; to facilitate the transaction of a member's day-to-day business; and to eliminate business disputes and misunderstandings that may arise from uncertainty and lack of uniformity in such matters, The subjects addressed in the Uniform Practice Code Advisories are subject to the provisions of the FINRA Uniform Practice Code (Rule 11000 Series), which is administered by FINRA Operations.

Date Sort descending UPC No. Title Format - Size
15-19 iHeartmedia, Inc. PDF - 466.78 KB
16-19 Synergy Pharmaceuticals, Inc. PDF - 260.69 KB
17-19 Katy Industries, Inc PDF - 401.49 KB
18-19 Jones Energy, Inc PDF - 404.64 KB
19-19 Aralez Pharmaceuticals Inc PDF - 400.77 KB
20-19 Orexigen Therapeutics, Inc. PDF - 400.02 KB
21-19 Pernix Therapeutics Hldgs, Inc. PDF - 401.66 KB
22-19 Triangle Pete Corp PDF - 393.89 KB
23-19 Exco Resources, Inc. PDF - 400.27 KB
24-19 Vanguard Natural Resources, Inc. PDF - 400.39 KB
25-19 Point.360 PDF - 407.43 KB
26-19 E-TRADE Financial Corporation – 5.875% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series A & 5.3% Fixed-to-Floating Rate Non-Cumulative Perpetual Preferred Stock, Series B. PDF - 270.54 KB
27-19 Fairway Energy, LP PDF - 401.82 KB
28-19 Egalet Corporation (Debt) PDF - 274.9 KB
29-19 European Metals Corporation PDF - 375.93 KB
30-19 Aegerion Pharmaceuticals, Inc. 2% Senior Unsecured Convertible Notes Due 08/15/2019 PDF - 403 KB
31-19 Quantum Fuel Systems Technologies Worldwide, Inc. PDF - 395.28 KB
32-19 Argos Therapeutics Inc PDF - 398.77 KB
33-19 Altaba, Inc. PDF - 535.75 KB
34-19 Aceto Corporation PDF - 395.8 KB
35-19 Ditech Holding Corporation PDF - 395.13 KB
36-19 Halcon Resources Corporation PDF - 433.91 KB
37-19 Rexhall Industries, Inc. PDF - 388.98 KB
38-19 PHI, Inc. PDF - 403.73 KB
39-19 Bristol Myers Squibb Co Contingent Value Rights (When Issued) PDF - 261.06 KB